Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01118962|
Recruitment Status : Completed
First Posted : May 7, 2010
Results First Posted : December 4, 2013
Last Update Posted : July 17, 2018
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
This study began enrollment in August 2010. The study completed in October 2012. The participant flow consists of the Safety Set (SS).
The Safety Set consists of all subjects that were dosed at least once with Lacosamide (LCM).